 NEWTOWN, Pa., Jan. 20, 2021 GLOBE NEWSWIRE -- Helius Medical Technologies, Inc. Nasdaq:HSDT TSX:HSM Helius or the Company, a neurotech company focused on neurological wellness, today provided comments in response to a press release issued by the Centers for Medicare Medicaid Services CMS on Tuesday, January 12, 2021. 